Zepp Health Corp (NYSE:ZEPP)

Q3 2025 Zepp Health Corp Earnings Call Transcript

Nov 4, 2025 / 01:30 AM GMT

Release Date Price: $34.84 (-6.02%)

Transcript

Key Points

Positve

Zepp Health Corp (ZEPP) reported a significant revenue growth of 78.5% year over year, highlighting the effectiveness of their strategic brand and product evolution.
The company successfully turned its cash balance from outflow to inflow, marking a critical operational milestone.
The launch of the Amazfit T-Rex 3 Pro was well-received, particularly among endurance athletes and outdoor enthusiasts, setting new benchmarks in the premium outdoor segment.
Gross margin improved sequentially from 36.2% to 38%, driven by effective mix management and ongoing margin improvement initiatives.
Zepp Health Corp (ZEPP) achieved operating breakeven in Q3 2025, a significant improvement from the previous year's adjusted operating loss of $11.3 million.

Negative

The company faced supply constraints with the Helio Strap due to memory chip shortages and typhoon-related shipment delays.
Gross margin declined year over year from 40.6% to 38.2%, primarily due to lower pricing on entry-level products and promotional discounts.
Inventory levels increased slightly as the company built up stock to prepare for upcoming product launches and peak season, which could indicate potential overstock risks.
The macroeconomic landscape, including tariff impacts and memory chip price increases, posed challenges to the company's operations.
Despite strong product launches, the company remains cautious in its Q4 guidance, reflecting potential uncertainties in demand and supply chain improvements.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ZEPP.N - Zepp Health Corp
Q3 2025 Zepp Health Corp Earnings Call
Nov 05, 2025 / 01:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello ladies and gentlemen, thank you for standing by for Zep Health Corporation's 3rd quarter 2025 earnings conference call. At this time, all participants are in listen-only mode. Today's conference call is being recorded.

I will now hand the call over to your host, Ms. Grace Sack, director of investor relations for the company. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Grace.

Hello everyone and welcome to Depp House Corporation's 3rd quarter 2025 earnings conference call. The company's financial and operating results were issued in a press

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.